CORBETT MEDICAL PRACTICE — All Prescriptions & Medications — Page 13
Practice Code: M81091 | DROITWICH, WR9 7BE
Showing results 601-650 of 671
| Medication | Items (12m) ↓ | Quantity | Cost | vs National |
|---|---|---|---|---|
| Dapsone | 13 | 1,064 | £425 | +25.8% ▲ |
| Itraconazole | 13 | 586 | £267 | -3.1% ▼ |
| Mebendazole | 13 | 244 | £18 | +13.6% ▲ |
| Magnesium aspartate | 13 | 589 | £530 | -14.2% ▼ |
| Calcium acetate | 13 | 1,428 | £103 | -29.8% ▼ |
| Tube feed 1.2 kcal/ml with fibre, higher protein (0914011) | 13 | 336.0K | £6.0K | +19.2% ▲ |
| Ciprofloxacin | 13 | 100 | £89 | +63.6% ▲ |
| Apraclonidine | 13 | 242 | £927 | +3.2% ▲ |
| 13 | 135 | £874 | +63.2% ▲ | |
| 13 | 620 | £31 | -23.1% ▼ | |
| 13 | 25 | £761 | +43.3% ▲ | |
| 13 | 13 | £497 | +49.3% ▲ | |
| 13 | 420 | £783 | +1.6% vs avg | |
| 13 | 400 | £193 | +62.1% ▲ | |
| 13 | 420 | £231 | +151.9% ▲ | |
| 13 | 780 | £2.8K | -42.0% ▼ | |
| 13 | 420 | £241 | +22.2% ▲ | |
| Sucralfate | 12 | 2,480 | £2.8K | +42.9% ▲ |
| Losartan potassium with diuretic | 12 | 336 | £39 | -53.2% ▼ |
| Omega-3-acid ethyl esters | 12 | 1,120 | £542 | -43.2% ▼ |
| Domperidone | 12 | 350 | £8 | -66.4% ▼ |
| Pioglitazone hydrochloride | 12 | 784 | £26 | -86.4% ▼ |
| Raloxifene hydrochloride | 12 | 672 | £96 | -18.8% ▼ |
| Ciclosporin | 12 | 560 | £635 | -28.1% ▼ |
| Sodium chloride | 12 | 225 | £122 | +43.6% ▲ |
| Powder fibre fortifier (0913151) | 12 | 5,250 | £284 | +54.4% ▲ |
| Liquid OTC glucose for diabetic hypo treatment (0913541) | 12 | 4,800 | £75 | -47.6% ▼ |
| Tube feed additive 0.5 kcal/ml high fibre liquid (0914052) | 12 | 8,926 | £362 | +24.5% ▲ |
| Loteprednol etabonate | 12 | 60 | £63 | +29.7% ▲ |
| Betamethasone sodium phosphate | 12 | 120 | £27 | +80.1% ▲ |
| Clindamycin phosphate | 12 | 1,020 | £173 | -27.0% ▼ |
| 12 | 230 | £338 | -23.5% ▼ | |
| 12 | 82 | £582 | +99.7% ▲ | |
| 12 | 125 | £627 | +11.9% ▲ | |
| 12 | 273 | £972 | -27.9% ▼ | |
| 12 | 1,870 | £87 | -77.9% ▼ | |
| 12 | 120 | £375 | -41.1% ▼ | |
| 12 | 270 | £391 | -63.4% ▼ | |
| 12 | 1,440 | £352 | +33.5% ▲ | |
| 12 | 720 | £2.3K | +2.2% ▲ | |
| 12 | 978 | £90 | -56.3% ▼ | |
| 12 | 300 | £934 | +40.2% ▲ | |
| Co-amilozide (Amiloride hydrochloride/hydrochlorothiazide) | 11 | 728 | £328 | -32.7% ▼ |
| Bempedoic acid/Ezetimibe | 11 | 616 | £1.2K | -82.0% ▼ |
| Tiotropium bromide/olodaterol | 11 | 18 | £556 | -82.1% ▼ |
| Indacaterol/glycopyrronium | 11 | 330 | £340 | -75.6% ▼ |
| Apomorphine hydrochloride | 11 | 90 | £2.3K | -0.8% vs avg |
| Urine testing reagents | 11 | 750 | £41 | -1.6% vs avg |
| Levonorgestrel | 11 | 1,245 | £31 | +35.3% ▲ |
| Ready to serve 4.5 - 5 kcal/ml energy (fat) liquid (0913142) | 11 | 5,400 | £179 | -1.9% vs avg |
Data sourced from NHSBSA English Prescribing Dataset, CQC, and GP Patient Survey. Prescribing data does not indicate quality of care. Higher prescribing rates may reflect patient demographics. Always consult your GP for medical advice.